Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma [6]

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 91-

  Marisavljević, Dragomir ^a   Ristić, Biljana ^a   Hajder, Jelena ^a  

^a Auto Put bb   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIHISTAMINIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; GEMCITABINE; PREDNISONE; PROCARBAZINE; STEROID; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE;

ADULT; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; DERMATITIS; FEMALE; HODGKIN DISEASE; HUMAN; LETTER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RECALL DERMATITIS; RADIATION SICKNESS; SKIN MANIFESTATION; TREATMENT FAILURE;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DERMATITIS; FEMALE; HODGKIN DISEASE; HUMANS; MECHLORETHAMINE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

EID: 24344506009     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20379     Document Type: Letter

References (4)

1. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59:237-245.
2. Brandes A, Reichmann U, Plasswilm L, Bamberg M. Time and dose limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine-a report of three cases. Anticancer Drugs 2000;11:15-17.
3. Schwartz BM, Khuntia D, Kennedy AW, Markman M. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol 2003;91(2):421-422.
4. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004;100(9):1793-1799.